Insider Transactions in Q2 2018 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q2 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2018
|
Adam H Schechter EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Indirect |
34,094
-35.2%
|
$2,079,734
$61.0 P/Share
|
|
Jun 18
2018
|
Adam H Schechter EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Direct |
100,000
-100.0%
|
$6,100,000
$61.0 P/Share
|
|
Jun 18
2018
|
Adam H Schechter EVP & Pres-Global Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+50.0%
|
$3,600,000
$36.56 P/Share
|
|
May 15
2018
|
Julie L. Gerberding EVP, Chief Patient Officer |
SELL
Open market or private sale
|
Direct |
9,972
-17.91%
|
$588,348
$59.66 P/Share
|
|
May 01
2018
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
SELL
Payment of exercise price or tax liability
|
Direct |
1,142
-2.17%
|
$66,236
$58.87 P/Share
|
|
May 01
2018
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Exercise of conversion of derivative security
|
Direct |
4,009
+7.08%
|
-
|
|
May 01
2018
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,030
-4.64%
|
$59,740
$58.87 P/Share
|
|
May 01
2018
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
3,007
+11.93%
|
-
|
|
May 01
2018
|
Ashley Watson SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,151
-24.65%
|
$182,758
$58.87 P/Share
|
|
May 01
2018
|
Ashley Watson SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,441
+44.96%
|
-
|
|
Apr 16
2018
|
Weir Mirian M Graddick Exe V-P, HR |
SELL
Open market or private sale
|
Direct |
24,000
-22.98%
|
$1,392,000
$58.0 P/Share
|